Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation
Open Access
- 1 January 2015
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2015, 1-9
Abstract
Background. There is a growing amount of evidence that inflammatory processes are involved in the development of atrial fibrillation (AF) and its complications. We decided to investigate the behavior of osteoprotegerin (OPG) and TNF-related apoptosis inducing ligand (TRAIL) in terms of acute onset of AF. Methods and Results. We included 60 patients with acute onset of AF, candidates for pharmacological cardioversion. The presence of cardiovascular comorbidities was connected with higher concentration of OPG and lower level of TRAIL right from the first hours of AF paroxysm. The initial TRAIL level correlated also positively with left ventricle ejection fraction and negatively with left atrium diameter. We found subsequent increase of OPG in subgroups selected on the basis of CHA2DS2-VASc scoring. Although basal concentrations of studied markers did not allow prediction of the restoration of sinus rhythm, we observed important increase of TRAIL concentration in subgroup with sinus rhythm maintenance (94.11 ± 29.46 versus 111.39 ± 30.23 pg/mL; ). Conclusions. OPG and TRAIL are associated with the underlying cardiovascular damage in AF, but their balance is modulated by the fact of sinus rhythm restoration. Determining the suitability of OPG and TRAIL as predictive markers in AF requires further prospective studies.
Keywords
Funding Information
- Jagiellonian University
This publication has 29 references indexed in Scilit:
- Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysisInternational Journal of Cardiology, 2013
- Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjectsHypertension Research, 2012
- Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart SurveyEP Europace, 2012
- Atrial fibrillation management: a prospective survey in ESC Member CountriesEuropean Heart Journal, 2005
- Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factorJournal of Cellular Physiology, 2005
- The Role of Osteoprotegerin and Tumor Necrosis Factor-related Apoptosis-inducing Ligand in Human Microvascular Endothelial Cell SurvivalMolecular Biology of the Cell, 2004
- Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular DiseaseCirculation, 2004
- Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) Sequentially Upregulates Nitric Oxide and Prostanoid Production in Primary Human Endothelial CellsCirculation Research, 2003
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Serum Osteoprotegerin Levels Are Associated With the Presence and Severity of Coronary Artery DiseaseCirculation, 2002